Association of Sarcoidosis With Increased Risk of VTE: A Population-Based Study, 1976 to 2013
- PMID: 27687848
- PMCID: PMC5310113
- DOI: 10.1016/j.chest.2016.09.009
Association of Sarcoidosis With Increased Risk of VTE: A Population-Based Study, 1976 to 2013
Abstract
Objective: The goal of this study was to investigate the risk of VTE among patients with sarcoidosis.
Methods: A cohort of 345 incident cases of sarcoidosis and 345 sex- and age-matched comparator subjects in Olmsted County, Minnesota, from 1976 to 2013 were identified from the comprehensive medical record linkage system. Medical records were reviewed for DVT and pulmonary embolism (PE). The cumulative incidence was estimated, adjusted for the competing risk of death. Cox proportional hazards models were used to compare the rate of development of these events between patients with sarcoidosis and the nonsarcoidosis comparison cohort.
Results: The prevalence of VTE, DVT, and PE prior to the index date was not significantly different between case and comparator subjects. The risk of incident VTE adjusted for age, sex, and calendar year was significantly higher among patients with sarcoidosis (hazard ratio [HR], 3.04 [95% CI, 1.47-6.29]). Significantly elevated risk was observed in both subtypes of VTE, with an HR of 3.14 (95% CI, 1.32-7.48) for DVT and an HR of 4.29 (95% CI, 1.21-15.23) for PE. A sensitivity analysis including only VTE events that occurred at least 6 months after the index date adjusted for age, sex, and calendar year revealed somewhat lower HRs: VTE, 2.73 (95% CI, 1.30-5.72); DVT, 3.00 (95% CI, 1.25-7.20); and PE, 3.58 (95% CI, 0.98-13.03).
Conclusions: An increased risk of VTE among patients with sarcoidosis was observed in this population-based cohort.
Keywords: DVT; VTE; epidemiology; pulmonary embolism; sarcoidosis.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Sarcoidosis and Risk of VTE: Validation With Big Data.Chest. 2017 Jun;151(6):1398-1399. doi: 10.1016/j.chest.2017.03.022. Chest. 2017. PMID: 28599933 No abstract available.
-
Response.Chest. 2017 Jun;151(6):1399. doi: 10.1016/j.chest.2017.03.021. Chest. 2017. PMID: 28599935 No abstract available.
References
-
- Naess I.A., Christiansen S.C., Romundstad P. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692–699. - PubMed
-
- Anderson F.A., Zayaruzny M., Heit J.A. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82(9):777–782. - PubMed
-
- Prandoni P., Noventa F., Ghirarduzzi A. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92(2):199–205. - PubMed
-
- Silvarino R., Danza A., Merola V. Venous thromboembolic disease is systemic autoimmune diseases: an association to keep in mind. Autoimmun Rev. 2012;12(2):289–294. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
